 I. To evaluate the anti-cGVHD activity of extracorporeal photopheresis ECP when combined with low dose IL-2 interleukin 2 aldesleukin, in patients with steroid refractory cGVHD, as assessed by overall cGVHD response rate complete response CRpartial response PRstable disease SD. 